Simple Healthkit Inc

EnColl Corporation, established in 1994 and based in Fremont, CA, specializes in the development, manufacture, and marketing of high-purity Type-I collagen-based products. Utilizing patented technology, the company produces collagen that is 99% pure, ensuring minimal immunogenicity and high bioactivity for various medical applications, including wound healing and tissue regeneration. One of EnColl's flagship products, Helicoll, serves as an acellular skin substitute designed to promote blood vessel regeneration and support cellular migration, making it a valuable tool in wound management. Committed to stringent quality control standards, EnColl's products cater to a wide range of biomedical applications and have demonstrated significant efficacy in clinical settings. Generated from the website

Biolytic Lab Performance, Inc. is a leading provider of high-quality synthesis consumables and instruments for DNA and RNA oligo synthesis. Their Dr. Oligo synthesizers offer a range of synthesis scales and capabilities, ensuring consistent and reliable results for various applications. With a wide selection of accessories and parts, Biolytic Lab Performance also offers support and training to streamline downstream processes and optimize oligo synthesis. Headquartered in Fremont, CA, Biolytic Lab Performance is dedicated to delivering innovative solutions for the life sciences industry. Their commitment to quality and customer satisfaction has made them a trusted partner for researchers and scientists worldwide.Generated from the website

Applied Stemcell Inc, located in Milpitas, CA, specializes in advanced gene editing technologies and services, including the TARGATT large knock-in platform and proprietary iPSC services. The company offers a range of solutions, from custom and off-the-shelf disease models to cGMP cell banking, aimed at accelerating the development of innovative therapeutics. With a strong focus on quality and regulatory compliance, Applied Stemcell provides proven CRO and CDMO services that support clients in creating fit-for-purpose cell lines and advancing their cell therapy development. Their technologies ensure genomic stability and enable hypoimmunogenic cell lines suitable for therapeutic applications and immune evasive payloads. Generated from the website